Prevalence, severity, and predictors of symptom burden among adolescents and young adults with cancer
Cancer Medicine · 2023-05 · 12 (10) · 11773-11785
DOI: 10.1002/cam4.5837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 27.03.2023. Verfasst von Sumit Gupta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada. Hauptthemen laut MEDLINE: Quality of Life, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Terry Fox Research Institute, Institute for Clinical Evaluative Sciences.
Abstract (Originalsprache)
Background
Symptom burden in adolescents and young adults (AYA) with cancer is poorly characterized but impacts quality of life.
Methods
All Ontario, Canada AYA aged 15–29 years at diagnosis between 2010 and 2018 were linked to population‐based healthcare databases, including to Edmonton Symptom Assessment System‐revised (ESAS) scores, an 11‐point scale routinely obtained at the time of cancer‐related outpatient visits and collected provincially. Multistate models estimated mean duration of symptom severity states [none (0) vs. mild (1 vs. 2 vs. 3) vs. moderate (4–6) vs. severe (7–10)], trajectories, and subsequent mortality risk. Variables associated with severe symptoms were also determined.
Results
In total, 4296 AYA with ≥1 ESAS score within a year of diagnosis were included (median age 25 years). Prevalent moderate/severe symptoms included fatigue (59% of AYA) and anxiety (44%). Across symptom type, AYA reporting moderate symptoms were likelier to subsequently experience improvement versus worsening. Risk of death within 6 months increased with increasing symptom burden and was highest in AYA with severe dyspnea (9.0%), pain (8.0%), or drowsiness (7.5%). AYA in the poorest urban neighborhoods were more likely to experience severe symptoms than in the wealthiest areas, with twice the odds of reporting severe depression [adjusted odds ratio (OR) 1.95, 95th confidence interval (95% CI) 1.37–2.78], pain (OR: 1.94, 95% CI: 1.39–2.70), and dyspnea (OR: 1.96, 95% CI: 1.27–3.02).
Conclusions
AYA with cancer experience substantial symptom burden. Risk of death increased with symptom severity. Interventions targeting cancer fatigue and anxiety, and targeting AYA in lower‐income neighborhoods, are likely to improve quality of life in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.
- Cancer Research Program, ICES, Toronto, Canada.
- Institute for Health Policy, Evaluation and Management, University of Toronto, Toronto, Canada.
- Faculty of Medicine, University of Toronto, Toronto, Canada.
- Department of Supportive Care, Princess Margaret Cancer Centre, Toronto, Canada.
- Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
ORCID-Profile: Sumit Gupta, Rinku Sutradhar
Förderung
- Canadian Institutes of Health Research
- Terry Fox Research Institute
- Institute for Clinical Evaluative Sciences
- Ontario Ministry of Health and Long-Term Care
Zitieren
APA
Gupta, S., Li, Q., Nathan, P. C., D'Agostino, N., Baxter, N. N., Fox, C., Chalifour, K., Coburn, N., & Sutradhar, R. (2023). Prevalence, severity, and predictors of symptom burden among adolescents and young adults with cancer. Cancer Medicine, 12(10), 11773-11785. https://doi.org/10.1002/cam4.5837
Vancouver
Gupta S, Li Q, Nathan PC, D'Agostino N, Baxter NN, Fox C, et al. Prevalence, severity, and predictors of symptom burden among adolescents and young adults with cancer. Cancer Medicine. 2023;12(10):11773-11785. doi:10.1002/cam4.5837
BibTeX
@article{Gupta2023,
author = {Gupta, Sumit and Li, Qing and Nathan, Paul C and D'Agostino, Norma and Baxter, Nancy N and Fox, Colleen and Chalifour, Karine and Coburn, Natalie and Sutradhar, Rinku},
title = {Prevalence, severity, and predictors of symptom burden among adolescents and young adults with cancer},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {10},
pages = {11773--11785},
doi = {10.1002/cam4.5837}
}
EUVIMED